DGNS low risk high potential CL 236
TP1 278
TP2 430
please DYOR
DGNS potentially to the moon since its already takes sometimes for consolidation period.
Long
PT Diagnos Laboratorium Utama Tbk
No trades
No trades
2 IDR
2.94 B IDR
166.62 B IDR
275.00 M
Company info
Sector
Industry
CEO
Fergus Richard
Website
Headquarters
Jakarta
Founded
2007
IPO date
Jan 15, 2021
ISIN
ID1000158702
FIGI
BBG00YJ4QPJ2
Identifiers
ISIN ID1000158702
PT Diagnos Laboratorium Utama Tbk engages in the provision of health support service. Its products include clinical pathology laboratory, anatomy pathology laboratory, and genomics laboratory. Its services include home care health tests, corporate health tests, and Covid-19 tests. The company was founded on August 29, 2007 and is headquartered in Jakarta, Indonesia.
Summarizing what the indicators are suggesting.
Oscillators
Neutral
Oscillators
Neutral
Summary
Neutral
Summary
Neutral
Summary
Neutral
Moving Averages
Neutral
Moving Averages
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of DGNS is 286 IDR — it has decreased by −2.67% in the past 24 hours. Watch PT Diagnos Laboratorium Utama Tbk stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on IDX exchange PT Diagnos Laboratorium Utama Tbk stocks are traded under the ticker DGNS.
DGNS stock has risen by 3.55% compared to the previous week, the month change is a 4.29% rise, over the last year PT Diagnos Laboratorium Utama Tbk has showed a 101.41% increase.
DGNS reached its all-time high on Jul 5, 2021 with the price of 1,486 IDR, and its all-time low was 122 IDR and was reached on Mar 24, 2025. View more price dynamics on DGNS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
DGNS stock is 2.82% volatile and has beta coefficient of 0.75. Track PT Diagnos Laboratorium Utama Tbk stock price on the chart and check out the list of the most volatile stocks — is PT Diagnos Laboratorium Utama Tbk there?
Today PT Diagnos Laboratorium Utama Tbk has the market capitalization of 412.50 B, it has decreased by −2.01% over the last week.
Yes, you can track PT Diagnos Laboratorium Utama Tbk financials in yearly and quarterly reports right on TradingView.
DGNS net income for the last quarter is −1.71 B IDR, while the quarter before that showed −1.32 B IDR of net income which accounts for 0.00% change. Track more PT Diagnos Laboratorium Utama Tbk financial stats to get the full picture.
PT Diagnos Laboratorium Utama Tbk dividend yield was 0.00% in 2025, and payout ratio reached 0.00%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Oct 13, 2026, the company has 81 employees. See our rating of the largest employees — is PT Diagnos Laboratorium Utama Tbk on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PT Diagnos Laboratorium Utama Tbk EBITDA is 16.83 B IDR, and current EBITDA margin is 9.84%. See more stats in PT Diagnos Laboratorium Utama Tbk financial statements.
Like other stocks, DGNS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PT Diagnos Laboratorium Utama Tbk stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PT Diagnos Laboratorium Utama Tbk technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PT Diagnos Laboratorium Utama Tbk stock shows the buy signal. See more of PT Diagnos Laboratorium Utama Tbk technicals for a more comprehensive analysis.